Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
D'Alessandro
A M
AM
Department of Surgery, University of Wisconsin School of Medicine, Madison 53792.
Pirsch
J D
JD
Stratta
R J
RJ
Sollinger
H W
HW
Kalayoglu
M
M
Belzer
F O
FO
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D003586:Cytomegalovirus Infections / Q000628:therapy*; D015774:Ganciclovir; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D016031:Liver Transplantation
D000998:Antiviral Agents; D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir; D000212:Acyclovir